BRAF and neoplasm: Mutation hierarchy in thyroid cancers is nicely evidenced by data generated for the most aggressive thyroid cancers, PDTC and ATC, carrying mutations in TERT promoter gene (42.3% in PTDC and 73.5% in ATC), suggesting that the initial BRAF+ve subpopulation is lost during the tumour progression and the TERT+ve cells have a positive growth selection over the others, becoming more aggressive [23].